5 Stocks to Double In Value

Access each jackpot play… plus…
the exact trading strategy to squeeze out maximum gains as these stocks skyrocket in value…


Dear Reader:

Parkinson’s Disease (PD) affects over one million people in the United States alone.

About 50,000 to 60,000 new cases are reported every year.

By available estimates, it is a $2.7 billion industry.

And growing.

A small San Diego biotech is about to take the market by storm.

The common side effects of PD include mood swings and the inability to control motor functions.

Another (nastier side effect) is psychosis. But there’s good news for those who suffer. Because last year, this tiny biotech outfit successfully completed a pivotal Phase III trial for a breakthrough drug that treats PD psychosis symptoms.

Which is why I consider this firm my Top Stock to Buy Right Now.

Here’s where things get really exciting…

The FDA granted this company the Breakthrough Therapy Label.

Which means, the FDA wants to expedite the development and review of this drug. Because the drug proved itself effective enough to treat the serious symptoms of PD psychosis… without… causing additional side effects.

“In our study, [the drug] was able to significantly reduce psychotic symptoms in patients with moderate to severe Parkinson’s disease… efficacy was achieved without worsening parkinsonism and without other tolerability or safety concerns.” — The Lancet

Company shares skyrocketed upon FDA initial approval.

Analysts here at Wealthpire, Inc. are bullish on this obscure biotech.

They believe share prices are set to soar even higher in the coming weeks and months.

From an investment standpoint, this company is poised to snag a large share of the PD market.

The National Parkinson Foundation reports…

“In Western Europe’s five most populous nations and the world’s 10 most populous nations, a conservative estimate of the number of individuals with PD over age 50 was between 4.1 and 4.6 million in 2005 (Dorsey et al, 2007). By 2030, this number is expected, at a minimum, to double to between 8.7 and 9.3 million people with PD.”

Leading research firm, GlobalData, reports…

“As the prevalence of Parkinson’s Disease (PD) continues to grow thanks to an ageing population, its treatment market value is expected to increase… the US will have the largest PD therapeutics market share of 44% by 2022, expanding from 32% in 2012. This will be followed by Japan, Brazil and Germany, with respective shares of 13%, 11% and 10%.”

The statements above sum up both the unfortunate reality and the unprecedented opportunity.

This company has positioned itself currently as the only option for those suffering from PD psychosis. And that’s why analysts and financial industry leaders believe this company is about to experience a spike in share prices like never before.

CNN Money points out: “The current consensus among 5 polled investment analysts is to Buy stock in [the company]. This rating has held steady since November, when it was unchanged from a Buy rating.”

JMP Securities stated: “This is a patient population that has very limited treatment options right now. Being able to use a drug that’s as safe and as easy to use as this drug could be a really meaningful improvement for patients.”

Motley Fool says: “If you’re caring for someone with Parkinson’s disease or Alzheimer’s, you should be watching [this company].”

Please read the above statement by Motley Fool again.

It reveals yet another market this company can conquer with its breakthrough drug.

That market being… Alzheimer’s disease psychosis.

As many as 5 million Americans suffer with this disease. The national healthcare cost is estimated to top $100 billion annually according to the Alzheimer’s Foundation of America.

Once again, this tiny biotech may come to the rescue with the same drug.

The company’s CEO recently said…

“…we continue to advance enrollment of our ongoing Phase II study of [the drug] in Alzheimer’s disease psychosis and prepare for additional studies to evaluate the clinical utility of [the drug] in other areas of significant unmet medical need.”

Here at Wealthpire, Inc., my analysts and I believe company shares could soar by 214% in the coming weeks and months.

The reasons are simple:

Which is why I am issuing a Strong Buy Alert to all Wealthpire, Inc. insiders.

Now let me tell you about Top Stock #2 which is…

Reinventing The Automobile Market

You know those TV ads where cars park themselves?

Well, it turns out this company is at the forefront of supplying automakers with the technology.

The company designs and develops driver-assistance technology systems.

The software used in vehicles anticipates collisions, detects roadway markings… and even… reads traffic signs and lights.


The technology is truly cutting-edge. Which is why the company controls 80% of the vision system market. And it’s also why the company is a leader in the two fastest growing and powerful auto industry trends: autonomous automobiles and software.

Last summer, the firm went public with an $890 million IPO.

The IPO was well-received as share prices soared by 50% on the first day of trading. As of this writing, shares have jolted an additional 55%.

And the future looks bright. Auto industry experts predict the growth of the advanced driver assistance system (ADAS) market to surge from $18.2 billion in 2014 to above $50.48 billion by 2020.

Industry watchdogs and experts are raving about the technology:

“With [the company’s technology], a camera mounted behind the inside rearview mirror ‘reads’ the road ahead, monitoring such things as lane markings and the distance to the car in front… it will give you audible and visual warnings if your car begins leaving a lane, you’re following a car too closely, it senses a pedestrian or bicyclist, or it calculates that you need to take action to avoid hitting a car in front.” — Consumer Reports

“For a handful of investors, the future of mostly automated cars looks increasingly attractive… The longer-term goal [for the company is]… a semiautonomous vehicle that can handle many, but not all, driving functions without driver input.” — The New York Times

“… a study conducted by The People’s Insurance Company (Group) of China or PICC, showed that the [company’s] system reduces accidents by at least 30% and reduces fuel consumption by at least 3%.” — Star Motoring

The company has established partnerships with General Motors, Volvo and BMW.

The saftey technology it has innovated will soon become standard. In fact, new government car manufacturing regulations will likely mandate such technology be installed in every new vehicle.

Within the next 24 months, the company is gunning to have its system installed in 237 car models.

Which will forge futher partnerships with 20 manufacturers.

Deutsche Bank… Raymond James… Morgan Stanley… Wells Fargo… RBC… Citigroup, and Barclays are among the investment banks initiating buy ratings.

At Wealthpire, Inc. we’re bullish on this company.

We believe the company’s shares have a realistic chance of spiking by 210% in the near future.

My Top Stock #3 of 2015 is…

On The Cutting-Edge Of
The Multimedia Revolution

No doubt about it.

The multimedia market is driving economic change around the world.

And my next featured company is responsible for a handful of innovations consumers take for granted. HDMI, DVI and MHL are becoming standard in wireless high-definition applications.

Your television, PC, tablet and smartphone all use this technology.

It provides a better viewer experience with sharper, clearer pictures and sound.

This company has worked behind the scenes to bring the technology we enjoy to market.

The latest “Global Consumer Electronics Market Forecast 2018″ projects the growth of this market at a CAGR of 6.7% to 2018.

In addition, MarketsandMarkets (a global research firm) forecasts the global high-definition voice market to grow from $815 million in 2014 to $2.29 billion by 2019.

A boom is ahead for high-definition devices and this company is there to supply the growing demand.

The company’s technology is installed in:

We’re excited about this company.

All the stars seem to be aligning for it to see a big surge in its stock

I’m recommending it with no reservations because the company is:

In addition to the above, seminconductor mergers and acquisitions are hot.

The company is listed by Hedgeye Risk Management as a top acquisition target.

Regardless, we believe company share prices can rise as high as 220% in the next few months.

While that sounds good, my fourth Top Stock of 2015 is…

An Investment Software Firm Whose
Shares Are Set To Boom By Up To 250%

The New York Fed says, on a typical day, more than $14 trillion flow through our financial system.

If you stacked that enormous sum of money in a line of $1 bills, it would stretch from Earth past Uranus. Roughly speaking, that’s about… 1.8 billion miles!

A portion of that money is generated by Wall Street hedge funds and financial firms.

The next Top Stock is a company determined to dominate a unique niche.

It provides a cloud-based trading and portfolio management platform to these firms. Order and execution management. Real-time risk management. Reporting. Shadow accounting. Managed services.

All of these solutions are part of the software’s single user-friendly platform. And all of these services are crucial to the smooth operation of money management firms.

A big reason Wall Street firms are moving to a single order, execution and risk management solution is for easier regulatory compliance.

Just as crucial, this company’s solution allows hedge funds to achieve improved “operational alpha.”

In other words, this software helps lower a hedge fund’s operational costs… and… as a result… the fund’s overall performance gets a boost.

Industry experts agree:

“The main advantage would be the ease of use and lower cost of operation of a multiasset and modular system that will allow market participants to meet their regulatory requirements.” — Dr. Anshuman Jaswal, Senior Analyst, Celent

The global trade management software market is projected to grow at a CAGR of 10.92% to 2018.

Which will make this a billion-dollar industry.

From an investing standpoint, the company has a number of positive factors on its side:

Company shares are trading well below their potential.

The increased demand in cloud-based trading management solutions…

The company’s award-winning software niched to hedge funds and financial firms…

And the market’s overall projected growth lead me and my team to predict this company will see it’s shares jump up by up to 250% (or more) in the next few months.

The final pick rounding off my list of Top 5 Stocks for the year…

Develops Cyborg-Like Technology To Help People
With Spinal Cord Injuries… Walk Again

The National Spinal Cord Injury Statistical Center (NSCISC) released a number of sobering facts in August of 2014.

The World Health Organization estimates about 500,000 people world wide suffer such injuries.

Almost no one fully recovers.

Which is why I’m so excited about this company. It develops a cyborg-like exoskeleton device… that… according to the company:

“Provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors.”

People who can’t otherwise walk are now able to move about on their own.

The company’s mission is simple: “fundamentally changing the health and life experiences of individuals with spinal cord injuries.”

And it’s well on its way to making that mission a reality.

In the summer of 2014, the company’s technology was the first to be approved by the FDA. The company went public a few weeks later and shares shot up by 100% on the first day of trading.

Smart investors know a good thing when they see it. This company’s technology is the future of spinal cord injury treatment and rehabilitation.

It’s products are tested and government approved.

And they are life-changing for wheelchair-bound people who want to regain their mobility.

TIME magazine even listed this company’s technology as one of the top 25 inventions of 2013.

The fact is, as the world population increases, the prevalence of spinal cord injury will increase as well. This company’s innovations will help tens of thousands of people to live more productive lives.

And it has “first mover” advantage over the competition.

Wealthpire, Inc. analysts forecast company shares to rise by up to 239% in the next few months.

When you add it up, my Top 5 Stocks to Buy Right Now could result in 1,133% total returns over the next few months. That’s enough to…

… multiply a $25,000 stake into $283,250 in short order!

And if our projections are only half right, you can still pocket up to $141,625!

Heck, if we’re off by 75%… then… you’d still be ahead by $70,812 for the year!

But to make that happen, you need to know two things:

(1) Which companies represent my Top 5 Stocks.

And even more important…

(2) How to play these picks so you multiply returns quickly with supreme safety.

Hi, I’m Manny Backus.

For over a decade, I’ve been finding hot stocks set to “pop” big time.

And I’d like to give you full access to my Top 5 Stocks to Buy Right Now.

But first, a little background on me just in case you don’t know who I am.

I started Wealthpire, Inc. in 2002 with one goal in mind: To help street-level traders succeed wildly in the stock market.

And I’m happy to say that goal has been eclipsed over the years.

The company has grown like I never dreamed possible.

Enough to make the Inc. 500 list of the fastest-growing privately held companies in the U.S.

The reason for such success is simple.

At Wealthpire, Inc. I provide my valued subscribers with profit-rich stock picks.

And I do so on a consistent basis.

My speciality is finding the hidden market “gems” most brokers, analysts and TV talking-heads completely overlook.

These stocks are backed by reliable companies with great products or services… which are… positioned to see their share prices fly off the charts.

But I don’t stop there…

Not only do I find these little-known winners… I also provide subscribers with a complete game plan to squeeze out maximum profits from each pick.

Subscribers receive both up-to-the-minute alerts… and… the exact trading formula to turn these plays into huge gains.

For example…

From January To November
2014 Just 5 Of My Profit Picks Resulted In 340.87% Returns

Subscribers were overjoyed when I told them about…

Abraxas Petroleum Corp. (NASDAQ: AXAS) — This oil and gas player is taking full advantage of the energy boom in the U.S. Between January and July of 2014, my subscribers were cashing in as shares shot up by 100.31%!

Hawaiian Holdings, Inc. (NASDAQ: HA) — I spotted this international airline carrier when shares hovered at $12.30. The potential this company presented was obvious. So I issued a buy signal in February 2014. By November 2014, shares had jumped 57.72%!

Exact Sciences Corporation (NASDAQ: EXAS) — This biotech specializes in developing diagnostic screening products to detect and prevent colorectal cancer. Subscribers were alerted in April to buy. Six months later, shares had vaulted by 94.41%!

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) — Another hot little biotech I discovered which focuses on fighting cancer and infectious diseases. Company shares rose 60.45% in a single month during the summer.

Zoetis, Inc. (NYSE: ZTS) — This drug maker develops medicines and vaccines to treat livestock. I noticed this was a solid healthcare play and issued a buy alert in June. Shares took off and by early November had bolted by 27.98%!

Not only did I alert subscribers to these hot picks… but… I also told them when to get in… when to get out… how to manage each trade… and… how to maximize their returns.

And you could have done it in less than a year of hands-off trading.

I cover all bases so my subscribers are in the best position to profit from my alerts.

Whether a stock goes up, down or sideways I have the situation covered.
Which is why…

Over 100,000 Traders Trust Wealthpire, Inc.
Stock Research And Recommendations

My passion is finding and capitalizing on money-making stocks in any market situation.

Using a proprietary research process, I’m able to harvest, mine, analyze and track the hottest stocks available. I know which stocks are on the list of Wall Street’s major hedge funds, financial institutions, analysts, paid newsletters and publications.

These legitimate sources of market data offer me an advantage most stock traders don’t have. I know the stocks picked by multiple expert sources as most likely to rise in value.

My sources supply me with up-to-the-minute information not available to street-level traders.

Furthermore, I scour this list to produce a shorter list of what I call “multi-verified” stocks. These are stocks picked by multiple sources. This is a huge key to my trading success.

Because only a handful of stocks chosen by reliable market experts make short list.

But I don’t stop there…

Once I compile my list of multi-verified and multi-sourced stocks… I then… put these picks through a vigorous analysis. I use a series of exclusive guidelines, filters and indicators.

The point of this analysis is to find the single best stock of the bunch.

I call these stocks… consensus picks.

Because there is a consensus — or agreement — among more than one reliable source the picks are potentially profitable. Maybe even wildly profitable.

That’s one of the biggest reasons for my consistent success.

Only choosing those stocks recommended by multiple reliable sources. And then further refining those picks to the one best pick based on my proprietary analysis.

I rely on a sane approach to active trading because I look for…

Medium-Term Plays That Turn Into Serious
Cash Profits Within 4 To 12 Months

The great thing is…

Investors and traders with access to my picks waste none of their precious time.

Gone are the days of toiling for weeks to find the right stock. Only to pick a loser because critical intelligence was unavailable.

Because for my subscribers…

Everything necessary to find and bank on the hottest medium-term stocks is done for you.

All of these picks are multi-source verified.

Each stock was vetted through my secret stock-picking process.

Then a specific trading blueprint was developed for each stock. So my subscribers can capitalize on… what I believe is… the inevitable rise in share prices for each pick.

I’d love to share my most recent hot stock picks with you…

If You’d Like, I’ll Hand You
My Top 5 Stocks to Buy Right Now
… Absolutely FREE

Just take me up on a FREE 30-Day Trial of my elite alert service Consensus Picks.

As my gift for giving it a try, I’ll give you all of the stellar stocks I discussed above… a complete report on each one… the exact trading blueprint I’ve already mapped out… and… the entry and exit points, trade management strategy and everything else you need to turn these plays into windfall profits as they soar to new highs.

The mission here at Consensus Picks is simple…

Make subscribers LOTS of money!

How? By scouring the market for stocks about to take off to new highs. I don’t limit myself to a certain sector or industry. Because huge profit opportunities abound throughout the market.

Instead, I look for cash-producing stocks backed by real companies with massive potential.

All of my picks are… like I said before… multi-sourced and multi-verified.

Giving me the confidence to recommend them to you.

As a FREE 30-Day Trial member to Consensus Picks, you receive these benefits:

Become A Member Today And I’ll
Give You These Extra Moneymaking
Reports On The House

FREE Report The 10-Second Secret for Income Investors. This indicator allows you to value most stocks and identify under-valued plays perfect for income and growth.

FREE Report How Aggressive Investors Can Supercharge Profits With Options. I’ll show you how to use options with my consensus picks. It’s a great way to multiply your gains and minimize… even eliminate… downside risk.

FREE Report How To Protect Yourself From Uncle Sam’s Prying Eyes. Protect your privacy during the NSA nationwide “legal” spying operation on U.S. citizens.

FREE Report Profit Like A Pro In An Hour A Day. Discover 10 surprising secrets used by top traders to rake in stock market profits on a daily basis.

FREE Report Obscene Profits From Ugly Stocks. Short the market’s worst stocks for huge profits as they nosedive.

All five of these reports reveal specific ways to reap greater returns in any market.

Each report would sell for $41 each, $205 for all five.

However, they’re yours for free as soon as you accept my invitation to a FREE 30-Day Trial of Consensus Picks.

To get on board all you need is…

A basic stock brokerage account… and… the ability to place trades online and by phone.

At least a $5,000 grubstake to trade with. The more the better… but… any less and you just won’t get the biggest bang for your trading dollars.

An Internet connection to access the online trading center… and… receive my email alerts.

If you’re good with that then…

Now’s The Time To Turn My Picks Into
A Small (Or Large) Trading Fortune

For the next 30 days, you’ll get my Consensus Picks alerts for… FREE!

But this offer is available to 475 new trial subscribers only.

Once I reach the limit then I shut off access until who knows when. No spots are ever “held.” Access to the FREE 30-Day Trial is given on a first come, first served basis.

As you can imagine, a special trial offer like this tends to fill up fast.

The way it works is simple: You get full access to Consensus Picks for 30 days. Just like paid subscribers. At the end of the free trial period it’s your choice if you want to continue or not.

There’s no obligation to go on unless you love this alert service.

If you stick around (like a lot of trail subscribers do), I’ll make you another great deal…

You may continue your subscription at the low rate of just $99/month. Cancel any time for any reason and get a full refund for that month.

And if you ever decide to move on, keep the Fast Start Kit and ALL of the FREE Special Reports (over $205 in value) as my thank you. We’ll part friends and that’s that.

The good news is many Free Trial subscribers have made enough during the trial to pay for one year or more worth of Consensus Picks. Take a look at what some of them had to say…

“Hey Manny. My name’s Bill and I just wanted to say thanks. I’ve been with you for about five months and I’ve been averaging about $5,923 a month, which is like $29,600 and something dollars. I’m very, very happy. All I do is just follow your lead, follow your trades, and I’ve been making a ton of money.

Bill C., Glendale, Arizona

“I’d like to congratulate you on your system. First and most importantly my portfolio is up higher and faster than any other system I’ve used. I’m making a lot of money – I mean a lot. I’m also free to do what I want during the day. I don’t have to sit in front of a computer all day. Thanks for offering so many different ways to get your alerts. I can even travel on vacation or business and keep trading with your system. I just check my email a few times a day, call in a trade or two and that’s it. Thanks again for the great calls.”

— Jim B., International Falls, Minnesota

“I’m extremely happy with how my portfolio is doing under your guidance. As of Friday’s close, it’s up $1,200 because of your calls — that’s 6% in 13 trading days! In reality the actual time I spend responding to your advice is at the most 10 minutes a day, which is probably less time per day than I’d normally spend just deleting junk mail.”

— George H., Atlanta, Georgia

“I started Consenus Picks… so far it is the best service I have ever tried… I am up over $7,786. I have sold 1/2 of some of my holdings to lock in profits so I am up a lot more then the $7,786. Looking forward to next weeks picks.”

— Lou M., Fort Wayne, Indiana

“I’ve been a member now for just about a month. I’m enjoying it so far. I sold SMSI for a 28% gain. RVBD I bought… and sold it at 52.25 a week later for a 12% gain. I’m very pleased so so far. I’m planning to continue. Thanks.

— Maria G., Livermore, California

“Manny, I look forward to Consensus Picks every week. I bought stock in OPK and now am looking at a 21% increase in about a month’s time. Keep up the good work.”

— Sean P., Austin, Texas

“… I am amazed at the accuracy of the stock calls. The service constantly keeps the user updated and answers any and all questions that are asked. I have tremendous confidence in this service – take the 30 day trial and you will see for yourself. You will be glad you did. I look forward to many future profitable trades using this service.”

— Bob B., Highland Heights, Ohio

“In just two short months I have made profits of $27,896.46. Not bad for a beginner!”

— Stan J., Cambridge, Massachusetts

The Next 30 Days Could Change Your
Financial Situation For the Better… Forever

As you can see, 30 days is plenty of time to rake in decent returns during the free trial.

So I encourage you to test drive this amazing service right now.

Get your hands on my multi-verified hot picks.

Place a few trades and watch as winner after winner plows profits into your trading account. Then… after you experience the huge upside and limited downside of being a Consensus Picks member… judge for yourself from experience whether it makes sense to continue or not.

But don’t worry!

You don’t have to make a decision either way for 30 days.

In the meantime, secure one of the remaining FREE Trial spots today.

You get a free 30-day subscription which entitles you to all my hot alerts. All I ask is that you cover the small $7.67 shipping and handling fee to mail the Fast Start Kit to your door.

Once your FREE Trial membership is approved (should only take about 5 minutes), you get instant access to the member website… and… all my current research and recommendations.

Plus the Top 5 Stocks to Buy Right Now and everything else I promised.

Then, over the next 30 days, expect an additional four (maybe more) alerts to come your way.

But don’t drag your feet. Only 475 FREE Trial memberships are available. They will fill up fast. They always do. When that happens, I can’t let anyone else in.

One more thing: If you are one of the 475 trial subscribers, I will send you a “mystery bonus” that will take your trading to a whole new level. No “outsiders” will ever get their hands on this but it’s all yours and you’re going to love it.

Go ahead and…

Subscribe NOW

You’re about to take an exciting ride on the “profit express.”

By taking advantage of the FREE 30-Day Trial to Consensus Picks, you can prove it to yourself with no risk and no hassles.

Thank you and I look forward to seeing you in the member’s area.

Manny Backus, CEO
Manny Backus Signature
WealthPire, Inc.
An Inc. 500 Company


 Wealthpire Inc. is a publisher of financial news and opinions and NOT a securities broker/dealer or an investment advisor. You are responsible for your own investment decisions. All information contained in our newsletters or on our web site(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing Wealthpire materials and websites, you agree to our Terms and Conditions of Use, including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our website. Disclaimer | Privacy Policy

3435 Ocean Park Blvd. #107 PMB 334, Santa Monica, CA 90405
Toll Free 800-670-8332 International 310-882-6440
© Wealthpire Inc. All Rights Reserved.